Lipid A domain of lipopolysaccharide (Lipid A)

Lipid A is the hydrophobic anchor of the lipopolysaccharide (LPS) molecule, situated within the outer membrane of Gram-negative bacteria (Raetz & Whitfield, 2002). It is widely recognized as the "endotoxin" responsible for the potent inflammatory response associated with Gram-negative infections (Alexander & Rietschel, 2001). Upon release into the bloodstream, Lipid A binds to the TLR4/MD-2 receptor complex on myeloid cells, initiating a signaling cascade that produces pro-inflammatory cytokines (Park & Lee, 2013). While this mechanism is vital for the innate immune response, excessive activation can lead to clinical conditions such as sepsis and septic shock (StatPearls, 2023). Lipid A is a primary pharmacological target for polymyxin antibiotics, which bind to its phosphate groups to destabilize the bacterial membrane (PubChem). Furthermore, therapeutic strategies involving Lipid A analogs or neutralizing agents, such as Eritoran or alkaline phosphatase, aim to prevent the progression of endotoxemia in critically ill patients (NIH).

Other names

EndotoxinLipid A moietyLPS Lipid ALipid A component

Polymyxin antibiotics bind to the Lipid A moiety of lipopolysaccharides, leading to the displacement of divalent cations and subsequent disruption of the bacterial outer membrane (PubChem). Other agents, such as Eritoran, act as competitive antagonists by binding to the MD-2/TLR4 complex, preventing Lipid A-induced signaling (Park & Lee, 2013). Additionally, enzymes like alkaline phosphatase detoxify Lipid A by removing phosphate groups essential for its biological activity (Alexander & Rietschel, 2001).